ABTB1

ABTB1 (BPOZ-2) is a substrate-recognition adaptor for CUL3-based E3 ubiquitin ligase complexes that directs target proteins for ubiquitin-proteasome degradation, coupling this activity to control of translation, cell-cycle progression, and inflammatory signaling (PMID:18459963, PMID:36936774). Acting downstream of PTEN, ABTB1 restrains cell growth and arrests the cell cycle at the G1/S transition (PMID:11494141); through its ankyrin repeats and tandem BTB/POZ domains it directly binds the translation elongation factor eEF1A1, blocks its GTP loading, and promotes its CUL3-dependent ubiquitylation and degradation, thereby suppressing translation (PMID:18459963). The same adaptor function targets CDK1 for K27-linked ubiquitination to gate the G2/M transition as a tumor suppressor in glioblastoma (PMID:42034143), and degrades NLRP3 to limit IL-1β production and inflammasome-driven pathology in vivo (PMID:36936774, PMID:38866194). ABTB1 is predominantly cytoplasmic but is recruited to the nucleus by TdIF1, where it promotes ubiquitylation of TdT (PMID:19930467). Its activity is set by opposing regulators: TRIM4 ubiquitinates and degrades ABTB1 (while ABTB1 reciprocally promotes TRIM4 degradation) (PMID:37823597, PMID:42034143), and TTLL12 competes for eEF1A1 binding to spare the substrate from degradation (PMID:42014684). ABTB1 also associates with PINK1 to drive autophagic clearance of alpha-synuclein in dopaminergic neurons (PMID:26916519).

1. 2001 Medium

   Established ABTB1 as a growth-suppressive effector by placing it in the cell-cycle control circuitry downstream of PTEN, answering whether the gene actively restrains proliferation.

   Evidence Colony-formation assays, stable overexpression, antisense knockdown and flow cytometry in cancer cells

   PMID:11494141

   Open questions at the time

   • No molecular mechanism for the G1/S arrest identified at this stage
   • Direct biochemical link to PTEN signaling not resolved
2. 2008 High

   Defined the core biochemical identity of ABTB1 as a CUL3 E3 ligase adaptor and identified eEF1A1 as a direct substrate, explaining a molecular route to translational suppression.

   Evidence Yeast two-hybrid, GST pull-down, co-IP, domain mapping, in vitro ubiquitylation and in vitro translation assays

   PMID:18459963

   Open questions at the time

   • Whether eEF1A1 degradation accounts for the cell-cycle phenotype not tested
   • Physiological contexts of translation suppression not defined
3. 2009 High

   Showed that ABTB1 localization and substrate choice are controlled by binding partners, with TdIF1 driving nuclear recruitment and TdT ubiquitylation.

   Evidence Yeast two-hybrid, pull-down, reciprocal co-IP, fluorescence co-localization and ubiquitylation assay in 293T cells

   PMID:19930467

   Open questions at the time

   • Functional consequence of nuclear TdT ubiquitylation in vivo unknown
   • Signals governing cytoplasmic-versus-nuclear partitioning not defined
4. 2016 Medium

   Extended ABTB1 function to neuronal proteostasis by linking it to PINK1-dependent autophagic clearance of alpha-synuclein.

   Evidence Lentiviral overexpression and shRNA knockdown in A53T transgenic mice, co-IP, immunohistochemistry

   PMID:26916519

   Open questions at the time

   • Whether ABTB1 acts as a CUL3 adaptor in this autophagy context unclear
   • Direct substrate in the PINK1 pathway not identified
5. 2023 High

   Identified NLRP3 as a degradation substrate, establishing ABTB1 as a negative regulator of inflammasome activation with disease relevance in sepsis and viral infection.

   Evidence Knockout mouse model, reciprocal co-IP, ELISA, immunoblot, BMDM assays and rescue experiment; SARS-CoV-2 N protein modulation

   PMID:36936774

   Open questions at the time

   • Ubiquitin linkage type on NLRP3 not characterized
   • Mechanism by which SARS-CoV-2 N protein lowers ABTB1 expression not resolved
6. 2023 Medium

   Revealed a regulatory interplay with TRIM4, showing ABTB1 promotes TRIM4 degradation and thereby influences influenza A virus replication.

   Evidence Co-IP, mass spectrometry, proteasome inhibition, IAV replication and nuclear import assays

   PMID:37823597

   Open questions at the time

   • Whether ABTB1 uses CUL3 to degrade TRIM4 not established
   • ABTB1 does not bind NP directly, leaving the chain of causation indirect
7. 2024 Medium

   Confirmed ABTB1 as a broad anti-inflammatory factor in vivo by showing its deficiency aggravates colitis and acute liver injury via elevated IL-1β.

   Evidence Knockout mouse model with DSS and DEN injury models, IL-1β ELISA, histopathology

   PMID:38866194

   Open questions at the time

   • Tissue-specific substrates driving each phenotype not dissected
   • Relative contribution of NLRP3 versus other targets not quantified
8. 2026 Medium

   Defined a TRIM4–ABTB1–CDK1 axis controlling G2/M, with ABTB1 degrading CDK1 via K27-linked chains and TRIM4 counteracting by degrading ABTB1, providing a mechanistic basis for tumor suppression in glioblastoma.

   Evidence Co-IP, ubiquitination assays, protein turnover, domain mapping, flow cytometry and xenograft model

   PMID:42034143

   Open questions at the time

   • Whether CDK1 degradation explains the earlier G1/S phenotype not reconciled
   • Generality of the axis beyond glioblastoma untested
9. 2026 Medium

   Showed that substrate availability is tuned competitively, as TTLL12 displaces ABTB1 from eEF1A1 to block its degradation and drive hepatocellular carcinoma proliferation.

   Evidence Co-IP, ubiquitination assay, knockdown/overexpression functional assays and in vivo tumor model

   PMID:42014684

   Open questions at the time

   • Structural basis of the competitive binding not resolved
   • Whether other substrates are similarly protected by competing partners unknown

• How ABTB1 substrate selection, ubiquitin-linkage specificity, and cytoplasmic/nuclear partitioning are coordinated across its diverse roles in translation, cell cycle, inflammation, and autophagy remains unresolved.
• No structural model of the ABTB1–CUL3 substrate complex
• Determinants of which substrate is engaged in a given cell type not defined
• Unifying logic linking the multiple substrate-specific axes not established